BioSpace News Archive

Omnicell, Inc. today announced the launch of Specialty Pharmacy Services, a turnkey offering with dedicated services to set up, operate, and optimize a specialty pharmacy program.

Surgalign Holdings, Inc. announced its HOLO Portal surgical guidance system won the 2022 Best New Spine Technology Award presented by Orthopedics This Week, the most widely read publication in the orthopedics industry.

Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn” or the “Company”), today announces that it is changing its name to Eterna Therapeutics Inc. (“Eterna”) to reflect its focus on developing advanced therapies using its extensively patented in-licensed mRNA cell engineering technologies.

Allogene Therapeutic today launched CAR T Together™, a first-of-its-kind effort comprised of leading clinical trial investigators who represent the field of clinicians committed to supporting the development of “off-the-shelf” (allogeneic) chimeric antigen receptor (CAR) T products to make CAR T therapy scalable and more accessible to patients with certain cancers.

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, is pleased to provide an update to its shareholders.

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, announced it acquired StoCastic, LLC., a leading artificial intelligence company that provides evidence-based decision support for hospital emergency departments.

Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection at ACG 2022.

Membrane Wrap – Hydro™, a hydrated human amnion membrane allograft by BioLab Sciences, has just been recognized by the Food and Drug Administration’s (FDA) Tissue Reference Group (TRG) as a human cell, tissue, or cellular or tissue-based product (HCT/P).

Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”) today announced plans to investigate the ability of BWV-201, a Streptococcus pneumoniae vaccine candidate for acute otitis media (“AOM”) prevention, to also protect against non-invasive pneumococcal pneumonia at the World Vaccine Congress in Barcelona.

Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced today that it has acquired an ecosystem of full-service medical device consultancy companies, providing regulatory and clinical affairs, quality assurance, and biocompatibility services for medical devices and in vitro diagnostic (IVD) devices.